Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Advances in Therapy|March 27, 2024
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled CorticosteroidsPeter T Daley-Yates, Bhumika Aggarwal, Maximilian Plank
The Journal of Allergy and Clinical Immunology|May 17, 2011
Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatmentAdam Collison, Joerg Mattes, Maximilian Plank, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2014
MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expressionSteven Maltby, Maximilian Plank, Catherine Ptaschinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2009
Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways diseaseJoerg Mattes, Adam Collison, Maximilian Plank, et al.
Frontiers in Physiology|February 13, 2016
Targeting MicroRNA Function in Respiratory Diseases: Mini-ReviewSteven Maltby, Maximilian Plank, Hock L Tay, et al.
Annals of Medicine|October 14, 2014
MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?Hock L Tay, Maximilian Plank, Adam Collison, et al.
Allergy|November 7, 2025
Decarbonising Respiratory Care: The Impact of a Low-Carbon Salbutamol Pressurised Metered-Dose InhalersJames King, Ashley Woodcock, Antonio Anzueto, et al.
Pageof 2